Rock Springs Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Rock Springs Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-809,854	Closed	-$2.02M	–	130
2022 Q2	$2.02M	Sell	809,854 -138,473	-15%	-$636K	0.06%	113
2022 Q1	$7.37M	Hold	948,327	–	–	0.19%	93
2021 Q4	$3.96M	Hold	948,327	–	–	0.09%	121
2021 Q3	$7.51M	Hold	948,327	–	–	0.16%	120
2021 Q2	$7.66M	Hold	948,327	–	–	0.15%	127
2021 Q1	$10.2M	Hold	948,327	–	–	0.22%	114
2020 Q4	$11.1M	Buy	948,327 +786	+0.1%	+$9.87K	0.24%	108
2020 Q3	$11.4M	Buy	947,541 +10,500	+1%	+$144K	0.29%	91
2020 Q2	$16.4M	Buy	+937,041	New	+$16.3M	0.45%	74

Other funds holding FUSN

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Rock Springs Capital Management's FUSN Position: Q3 2022 in Review

Rock Springs Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q3 2022, closing a stake of 809,854 shares — an estimated $2.02M sold.

Rock Springs Capital Management first reported a position in FUSN in Q2 2020 and held it in 9 quarters. The position peaked at $16.4M in Q2 2020. 34 funds tracked by Wall St. Rank hold FUSN as of Q3 2022.

Rock Springs Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
Rock Springs Capital Management sold 809,854 Fusion Pharmaceuticals Inc. Common Shares shares in Q3 2022, an estimated $2.02M.
Rock Springs Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 9 quarters.
Rock Springs Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $16.4M in Q2 2020.
34 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2022.

Based on Rock Springs Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.